08045804946
Send Inquiry
Product Video
Guficap (Caspofungin Acetate for Injection )
3999.0 INR/Number
Product Details:
- Indication Used for the treatment of invasive aspergillosis, candidemia, and other serious fungal infections
- Salt Composition Caspofungin Acetate
- Dosage Form Injection
- Feature Broad-spectrum antifungal, easy reconstitution, effective against resistant fungal strains
- Ingredients Caspofungin Acetate, excipients
- Application Antifungal agent for intravenous administration
- Physical Color/Texture Lyophilized powder, white to off-white in color
- Click to View more
X
Guficap (Caspofungin Acetate for Injection ) Price And Quantity
- 3999.0 INR/Number
- 1 Number
- Echinocandin antifungal
- Over approximately 1 hour
- For hospital use only, use under medical supervision
- Vial
- Intravenous (IV) infusion only
- Typically available in 50 mg and 70 mg per vial
- Sterile water for injection
Guficap (Caspofungin Acetate for Injection ) Product Specifications
- Caspofungin Acetate
- 24 months
- Antifungal agent for intravenous administration
- Used for the treatment of invasive aspergillosis, candidemia, and other serious fungal infections
- Lyophilized powder, white to off-white in color
- Broad-spectrum antifungal, easy reconstitution, effective against resistant fungal strains
- Injection
- Caspofungin Acetate, excipients
- Store below 25C, protect from light
- Odorless
- Echinocandin antifungal
- Over approximately 1 hour
- For hospital use only, use under medical supervision
- Vial
- Intravenous (IV) infusion only
- Typically available in 50 mg and 70 mg per vial
- Sterile water for injection
Guficap (Caspofungin Acetate for Injection ) Trade Information
- Cash Advance (CA), Cash in Advance (CID)
- 1000 Number Per Week
- 2 Days
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- All India
Product Description
Guficap contains Caspofungin Acetate, an antifungal medicine belonging to the echinocandin class. It is used for the treatment of serious fungal infections, especially when other antifungal treatments are not suitable or effective. The medication is supplied as a lyophilized powder that must be reconstituted and administered intravenously (IV) by healthcare professionals.
Caspofungin works by inhibiting the enzyme -(1,3)-D-glucan synthase, which is essential for forming the fungal cell wall. Without this protective cell wall, the fungus becomes weak and eventually dies. This mechanism makes Guficap effective against a variety of Candida and Aspergillus species.
Guficap is commonly used for the treatment of:
-
Invasive candidiasis, including candidemia (fungus in the bloodstream)
-
Intra-abdominal Candida infections
-
Esophageal candidiasis
-
Invasive aspergillosis, particularly in patients who do not respond to or cannot tolerate other therapies
-
Empirical therapy for presumed fungal infections in patients who are neutropenic (low white blood cell counts)
This medication is typically administered once daily, and dosage may vary based on the patient's age, liver function, and clinical condition. Guficap is generally well tolerated, and because it targets fungal cells specifically, it has fewer side effects compared to some older antifungal drugs.
FAQs About Guficap (Caspofungin Acetate 50 mg)
1. What is Guficap used for?
Guficap is used to treat serious fungal infections such as invasive candidiasis, intra-abdominal Candida infections, esophageal candidiasis, and invasive aspergillosis. It is also used as empirical therapy in neutropenic patients with suspected fungal infections.
2. How is Guficap given?
It is administered intravenously (IV) in a hospital or clinical setting. A healthcare professional prepares and injects the dose.
3. How does Guficap work?
Guficap blocks the production of an essential component of the fungal cell wall (-D-glucan). Without a strong cell wall, the fungus cannot survive.
4. How long does treatment usually last?
The duration varies depending on the infection and the patients response. Treatment can last anywhere from a few days to several weeks, as decided by the doctor.
5. What are the common side effects?
Possible side effects include:
-
Fever
-
Headache
-
Mild liver enzyme elevation
-
Redness or irritation at the injection site
-
Nausea
Most side effects are mild and temporary.
6. Can Guficap be used in children?
Yes, Caspofungin can be used in pediatric patients, but the dose must be adjusted based on weight and medical condition.
7. Is Guficap safe for people with liver problems?
It can be used, but the dose may need to be adjusted. The doctor will monitor liver function tests during treatment.
8. Can Guficap interact with other medications?
Yes. Certain medicines (e.g., cyclosporine, rifampin, some antivirals) may increase or decrease its levels. Always inform your doctor about any medications you are taking.
9. Is it safe during pregnancy or breastfeeding?
It should be used during pregnancy only if clearly needed. Breastfeeding safety is not well established. Always consult a doctor before use.
10. What should I do if I miss a dose?
Because it is given in a medical facility, missed doses are uncommon. The healthcare team will adjust the schedule if needed.
Broad-Spectrum Antifungal Efficacy
Guficap offers robust coverage against a wide range of fungal pathogens, including those resistant to conventional antifungals. It is especially effective in treating severe fungal infections such as invasive aspergillosis and candidemia, ensuring better management in critical care settings.
Flexible Dosing and Easy Preparation
Available in 50 mg and 70 mg vials, Guficap is presented as a white to off-white, odorless lyophilized powder. The medication is reconstituted with sterile water for injection, making preparation straightforward for healthcare professionals. Its administration is always performed via IV infusion over approximately one hour.
FAQ's of Guficap (Caspofungin Acetate for Injection ):
Q: How should Guficap (Caspofungin Acetate) be administered?
A: Guficap is for intravenous infusion only and should be administered under the supervision of a healthcare professional in a hospital setting. Each dose is infused over approximately one hour after reconstitution with sterile water for injection.Q: What are the main indications for using Guficap?
A: Guficap is indicated for the treatment of serious fungal infections, including invasive aspergillosis, candidemia, and other invasive Candida infections, especially in patients who are intolerant of or refractory to other antifungal therapies.Q: What is the process for preparing Guficap for infusion?
A: To prepare Guficap, reconstitute the lyophilized powder in the vial with sterile water for injection. Once dissolved, further dilute in a compatible IV solution before infusing intravenously over about one hour.Q: When is Guficap typically prescribed to patients?
A: Guficap is generally prescribed for patients diagnosed with serious fungal infections who require hospital-based care and for whom other antifungal agents may have failed or are contraindicated.Q: Where should Guficap be stored and what is its shelf life?
A: Guficap should be stored below 25C and protected from light. When stored properly, it has a shelf life of 24 months from the date of manufacture.Q: What benefits does Guficap offer over other antifungal agents?
A: Guficap provides broad-spectrum antifungal activity, is effective against resistant fungal strains, and is well-tolerated. Its easy reconstitution further facilitates its use in fast-paced hospital environments.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMSMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
